News
AstraZeneca’s Calquence plus chemoimmunotherapy approved in the US for patients with previously untreated mantle...
AstraZeneca’s Calquence (acalabrutinib) in combination with bendamustine and rituximab has been approved in the US for the treatment of adult patients with previously untreated mantle cell...
InflaRx gains European Commission approval for GOHIBIC to treat SARS-CoV-2-induced acute respiratory distress syndrome
The European Commission (EC) has granted marketing authorization under exceptional circumstances for InflaRx's GOHIBIC (vilobelimab) for the treatment of adult patients with SARS-CoV-2-induced acute...
Lyndra forms strategic clinical research and commercial manufacturing services collaboration with Thermo Fisher for...
Lyndra Therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, has entered a strategic collaboration with Thermo Fisher Scientific, in which Thermo Fisher will...
